Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1887

1.

Effects of long term storage on secondary metabolite profiles of cannabis resin.

Grafström K, Andersson K, Pettersson N, Dalgaard J, Dunne SJ.

Forensic Sci Int. 2019 May 25;301:331-340. doi: 10.1016/j.forsciint.2019.05.035. [Epub ahead of print]

PMID:
31202146
2.

Influence of the migration of radioactive contaminants in soil, resident occupancy, and variability in contamination on isodose lines for typical Northern European houses.

Hinrichsen Y, Finck R, Martinsson J, Rääf C, Andersson KG.

Sci Rep. 2019 May 27;9(1):7876. doi: 10.1038/s41598-019-44392-z.

3.

TRP Channels as Lower Urinary Tract Sensory Targets.

Andersson KE.

Med Sci (Basel). 2019 May 22;7(5). pii: E67. doi: 10.3390/medsci7050067. Review.

4.

Small amounts of involuntary muscle activity reduce passive joint range of motion.

Diong J, Gandevia SC, Nguyen D, Foo Y, Kastre C, Andersson K, Butler JE, Héroux ME.

J Appl Physiol (1985). 2019 May 23. doi: 10.1152/japplphysiol.00168.2019. [Epub ahead of print]

PMID:
31120813
5.

Trustful communication in the medical encounter: Perspectives of immigrated people with epilepsy.

Andersson K, Shadman A, Strang S.

Chronic Illn. 2019 May 9:1742395319846254. doi: 10.1177/1742395319846254. [Epub ahead of print]

PMID:
31072139
6.
7.

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake.

Rosestedt M, Andersson KG, Rinne SS, Leitao CD, Mitran B, Vorobyeva A, Ståhl S, Löfblom J, Tolmachev V, Orlova A.

Sci Rep. 2019 May 1;9(1):6779. doi: 10.1038/s41598-019-43145-2.

8.

Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects.

Andersson KE, Longstreth J, Brucker BM, Campeau L, Cheng L, Francis L, Fein S.

Pharm Res. 2019 Apr 29;36(6):92. doi: 10.1007/s11095-019-2628-1.

10.

Oxidative stress and lower urinary tract symptoms: cause or consequence?

Andersson KE.

BJU Int. 2019 May;123(5):749-750. doi: 10.1111/bju.14633. No abstract available.

PMID:
31008563
11.

Liver Transplantation for Recurrent Cholangitis From Von Meyenburg Complexes.

Panda N, Brackett D, Eymard C, Kawai T, Markmann J, Kotton CN, Andersson K, Yeh H.

Transplant Direct. 2019 Feb 11;5(3):e428. doi: 10.1097/TXD.0000000000000867. eCollection 2019 Mar.

12.

Streptozotocin-induced diabetes causes upregulation of serotonin (5-HT)2A/C receptors in lumbosacral cord motoneurons and down regulation of serotonergic paraneurons in the urethra.

Cao N, Huang J, Ni J, Si J, Gu B, Wang Z, Andersson KE.

Brain Res. 2019 Jul 15;1715:21-26. doi: 10.1016/j.brainres.2019.03.009. Epub 2019 Mar 14.

PMID:
30880116
13.

New concepts in regenerative medicine approaches to the treatment of female stress urinary incontinence.

Bennington J, Williams JK, Andersson KE.

Curr Opin Urol. 2019 Jul;29(4):380-384. doi: 10.1097/MOU.0000000000000617.

PMID:
30855380
14.

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers.

Dahlsson Leitao C, Rinne SS, Mitran B, Vorobyeva A, Andersson KG, Tolmachev V, Ståhl S, Löfblom J, Orlova A.

Int J Mol Sci. 2019 Mar 2;20(5). pii: E1080. doi: 10.3390/ijms20051080.

15.

Case 4-2019: An 18-Year-Old Man with Abdominal Pain and Hematochezia.

Shields HM, Scheid FJ, Pierce TT, Andersson KL, Conrad MF, Rosenthal MG, Martin SD.

N Engl J Med. 2019 Jan 31;380(5):473-485. doi: 10.1056/NEJMcpc1810391. No abstract available.

PMID:
30699318
16.

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111.

Rinne SS, Leitao CD, Mitran B, Bass TZ, Andersson KG, Tolmachev V, Ståhl S, Löfblom J, Orlova A.

Sci Rep. 2019 Jan 24;9(1):655. doi: 10.1038/s41598-018-36827-w.

17.

Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men.

Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Takeda M, Sawada N, Andersson KE, Takeda M.

World J Urol. 2019 Jan 23. doi: 10.1007/s00345-019-02647-4. [Epub ahead of print]

PMID:
30673830
18.

Increased Mental Illness and the Challenges This Brings for District Nurses in Primary Care Settings.

Bjorkman A, Andersson K, Bergström J, Salzmann-Erikson M.

Issues Ment Health Nurs. 2018 Dec;39(12):1023-1030. doi: 10.1080/01612840.2018.1522399. Epub 2019 Jan 9.

PMID:
30624130
19.

Cell Versus Chemokine Therapy Effects on Cell Mobilization to Chronically Dysfunctional Urinary Sphincters of Nonhuman Primates.

Williams JK, Mariya S, Suparto I, Lankford SS, Andersson KE.

Int Neurourol J. 2018 Dec;22(4):260-267. doi: 10.5213/inj.1836126.063. Epub 2018 Dec 31.

20.

Understanding and bridging the conservation-genetics gap in marine conservation.

Sandström A, Lundmark C, Andersson K, Johannesson K, Laikre L.

Conserv Biol. 2019 Jun;33(3):725-728. doi: 10.1111/cobi.13272. Epub 2019 Jan 9. No abstract available.

PMID:
30578637
21.

Kerma conversion factors for modern glass buildings in radioactively contaminated areas.

Hinrichsen Y, Andersson KG.

J Radiol Prot. 2019 Mar;39(1):161-175. doi: 10.1088/1361-6498/aaf6ca. Epub 2018 Dec 6.

PMID:
30523808
22.

Maximum Time Between Tests: A Digital Biomarker to Detect Therapy Compliance and Assess Schedule Quality in Measurement-Based eHealth Systems for Alcohol Use Disorder.

Zetterström A, Hämäläinen MD, Karlberg E, Winkvist M, Söderquist M, Öhagen P, Andersson K, Nyberg F.

Alcohol Alcohol. 2019 Jan 1;54(1):70-72. doi: 10.1093/alcalc/agy086.

PMID:
30541059
23.

Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis.

Andersson KME, Wasén C, Juzokaite L, Leifsdottir L, Erlandsson MC, Silfverswärd ST, Stokowska A, Pekna M, Pekny M, Olmarker K, Heckemann RA, Kalm M, Bokarewa MI.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E12063-E12072. doi: 10.1073/pnas.1810553115. Epub 2018 Dec 3.

24.

Navigating the Murine Brain: Toward Best Practices for Determining and Documenting Neuroanatomical Locations in Experimental Studies.

Bjerke IE, Øvsthus M, Andersson KA, Blixhavn CH, Kleven H, Yates SC, Puchades MA, Bjaalie JG, Leergaard TB.

Front Neuroanat. 2018 Nov 2;12:82. doi: 10.3389/fnana.2018.00082. eCollection 2018.

25.

Affibody‑mediated imaging of EGFR expression in prostate cancer using radiocobalt‑labeled DOTA‑ZEGFR:2377.

Mitran B, Andersson KG, Lindström E, Garousi J, Rosestedt M, Tolmachev V, Ståhl S, Orlova A, Löfblom J.

Oncol Rep. 2019 Jan;41(1):534-542. doi: 10.3892/or.2018.6792. Epub 2018 Oct 15.

PMID:
30320363
26.

Intraprostatic injections for lower urinary tract symptoms/benign prostatic enlargement treatment.

Lombardo R, Andersson KE, Tubaro A, De Nunzio C.

Minerva Urol Nefrol. 2018 Dec;70(6):570-578. doi: 10.23736/S0393-2249.18.03233-2. Epub 2018 Oct 3.

27.

Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms.

Serati M, Andersson KE, Dmochowski R, Agrò EF, Heesakkers J, Iacovelli V, Novara G, Khullar V, Chapple C.

Eur Urol. 2019 Jan;75(1):129-168. doi: 10.1016/j.eururo.2018.09.029. Epub 2018 Oct 4.

PMID:
30293906
28.

Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors.

Oroujeni M, Garousi J, Andersson KG, Löfblom J, Mitran B, Orlova A, Tolmachev V.

Cells. 2018 Sep 18;7(9). pii: E141. doi: 10.3390/cells7090141.

29.

Importance of Val567 on heme environment and substrate recognition of neuronal nitric oxide synthase.

Olsbu IK, Zoppellaro G, Andersson KK, Boucher JL, Hersleth HP.

FEBS Open Bio. 2018 Aug 20;8(9):1553-1566. doi: 10.1002/2211-5463.12503. eCollection 2018 Sep.

30.

Autotransporter-Mediated Display of a Naïve Affibody Library on the Outer Membrane of Escherichia coli.

Andersson KG, Persson J, Ståhl S, Löfblom J.

Biotechnol J. 2019 Apr;14(4):e1800359. doi: 10.1002/biot.201800359. Epub 2018 Sep 25.

PMID:
30179307
31.

Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy.

Zambon JP, Patel M, Hemal A, Badlani G, Andersson KE, Magalhaes RS, Lankford S, Dean A, Williams JK.

Neurourol Urodyn. 2018 Sep;37(7):2141-2150. doi: 10.1002/nau.23536. Epub 2018 Aug 31.

PMID:
30168617
32.

Introducing the concept of the isodose for optimisation of decontamination activities in a radioactive fallout scenario.

Hinrichsen Y, Finck R, Rääf C, Andersson KG.

J Radiol Prot. 2018 Dec;38(4):1293-1310. doi: 10.1088/1361-6498/aadd24. Epub 2018 Aug 28.

PMID:
30152408
33.

Peripartum Maternal Hepatitis B Care in a US Nationwide Data Set.

Chang MS, Wharam JF, Zhang F, LeCates RF, Morton-Eggleston E, Tuomala RE, Rutherford AE, Mutinga ML, Andersson KL, Brown RS Jr, Ukomadu C, Oken E.

J Clin Gastroenterol. 2018 Aug 24. doi: 10.1097/MCG.0000000000001122. [Epub ahead of print]

PMID:
30148764
34.

Influence of heme c attachment on heme conformation and potential.

Kleingardner JG, Levin BD, Zoppellaro G, Andersson KK, Elliott SJ, Bren KL.

J Biol Inorg Chem. 2018 Oct;23(7):1073-1083. doi: 10.1007/s00775-018-1603-3. Epub 2018 Aug 24.

PMID:
30143872
35.

Dentinogenesis imperfecta type II in Swedish children and adolescents.

Andersson K, Malmgren B, Åström E, Dahllöf G.

Orphanet J Rare Dis. 2018 Aug 22;13(1):145. doi: 10.1186/s13023-018-0887-2.

36.

Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017.

Andersson KE, Fry C, Panicker J, Rademakers K.

Neurourol Urodyn. 2018 Jun;37(S4):S117-S126. doi: 10.1002/nau.23516. Review.

PMID:
30133792
37.

Fibrosis and the bladder, implications for function ICI-RS 2017.

Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson KE.

Neurourol Urodyn. 2018 Jun;37(S4):S7-S12. doi: 10.1002/nau.23725.

PMID:
30133788
38.

6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE.

Abrams P, Andersson KE, Apostolidis A, Birder L, Bliss D, Brubaker L, Cardozo L, Castro-Diaz D, O'Connell PR, Cottenden A, Cotterill N, de Ridder D, Dmochowski R, Dumoulin C, Fader M, Fry C, Goldman H, Hanno P, Homma Y, Khullar V, Maher C, Milsom I, Newman D, Nijman RJM, Rademakers K, Robinson D, Rosier P, Rovner E, Salvatore S, Takeda M, Wagg A, Wagner T, Wein A; members of the committees.

Neurourol Urodyn. 2018 Sep;37(7):2271-2272. doi: 10.1002/nau.23551. Epub 2018 Aug 14. No abstract available.

PMID:
30106223
39.

Extended periprostatic nerve distributions on the prostate surface confirmed using diffusion tensor imaging.

Sievert KD, Hennenlotter J, Dillenburg T, Toomey P, Wöllner J, Zweers P, Pannek J, Andersson KE, Amend B.

BJU Int. 2019 Jun;123(6):995-1004. doi: 10.1111/bju.14508. Epub 2019 Jan 29.

PMID:
30091828
40.

Joint Nordic nuclear research to strengthen nuclear emergency preparedness after the Fukushima accident.

Andersson KG, Linde C, Magnússon SM, Physant F.

J Environ Radioact. 2018 Dec;192:440-447. doi: 10.1016/j.jenvrad.2018.07.023. Epub 2018 Aug 3. Review.

PMID:
30081311
41.

Evaluation of two commercial CT metal artifact reduction algorithms for use in proton radiotherapy treatment planning in the head and neck area.

Andersson KM, Dahlgren CV, Reizenstein J, Cao Y, Ahnesjö A, Thunberg P.

Med Phys. 2018 Oct;45(10):4329-4344. doi: 10.1002/mp.13115. Epub 2018 Sep 19.

PMID:
30076784
42.

The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Andersson KE, Choudhury N, Cornu JN, Huang M, Korstanje C, Siddiqui E, Van Kerrebroeck P.

Ther Adv Urol. 2018 Jul 6;10(8):243-256. doi: 10.1177/1756287218781255. eCollection 2018 Aug. Review.

43.

Neuroepithelial control of mucosal inflammation in acute cystitis.

Butler DSC, Ambite I, Nagy K, Cafaro C, Ahmed A, Nadeem A, Filenko N, Tran TH, Andersson KE, Wullt B, Puthia M, Svanborg C.

Sci Rep. 2018 Jul 20;8(1):11015. doi: 10.1038/s41598-018-28634-0.

44.

Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients.

Aldridge J, Pandya JM, Meurs L, Andersson K, Nordström I, Theander E, Lundell AC, Rudin A.

Arthritis Res Ther. 2018 Jul 20;20(1):150. doi: 10.1186/s13075-018-1648-2.

45.

Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.

Ponandai-Srinivasan S, Andersson KL, Nister M, Saare M, Hassan HA, Varghese SJ, Peters M, Salumets A, Gemzell-Danielsson K, Lalitkumar PGL.

Hum Reprod. 2018 Oct 1;33(10):1924-1938. doi: 10.1093/humrep/dey241.

PMID:
30020448
46.

Increased autophagy contributes to impaired smooth muscle function in neurogenic lower urinary tract dysfunction.

Eberli D, Horst M, Mortezavi A, Andersson KE, Gobet R, Sulser T, Simon HU, Salemi S.

Neurourol Urodyn. 2018 Nov;37(8):2414-2424. doi: 10.1002/nau.23705. Epub 2018 May 24.

PMID:
29797356
47.

The serotonin (5-hydroxytryptamine) 5-HT7 receptor is up-regulated in Onuf's nucleus in rats with chronic spinal cord injury.

Ni J, Cao N, Wang X, Zhan C, Si J, Gu B, Andersson KE.

BJU Int. 2019 Apr;123(4):718-725. doi: 10.1111/bju.14405. Epub 2018 Jun 15.

PMID:
29781566
48.

Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy.

Fusco DN, Ganova-Raeva L, Khudyakov Y, Punkova L, Mohamed A, Cheon SSY, Koirala P, Andersson KL, Jourdain G, Sureau C, Chung RT, Lauer G.

Front Med (Lausanne). 2018 Apr 30;5:97. doi: 10.3389/fmed.2018.00097. eCollection 2018.

49.

Influence of composition of cysteine-containing peptide-based chelators on biodistribution of 99mTc-labeled anti-EGFR affibody molecules.

Oroujeni M, Andersson KG, Steinhardt X, Altai M, Orlova A, Mitran B, Vorobyeva A, Garousi J, Tolmachev V, Löfblom J.

Amino Acids. 2018 Aug;50(8):981-994. doi: 10.1007/s00726-018-2571-1. Epub 2018 May 4.

50.

Comparison of experimental and calculated shielding factors for modular buildings in a radioactive fallout scenario.

Hinrichsen Y, Finck R, Östlund K, Rääf C, Andersson KG.

J Environ Radioact. 2018 Sep;189:146-155. doi: 10.1016/j.jenvrad.2018.04.005. Epub 2018 Apr 16.

PMID:
29673949

Supplemental Content

Loading ...
Support Center